Neurocrine Biosciences
This role provides strategic leadership for the lifecycle management of assigned commercial-stage and near-launch products, focusing on maximizing long-term patient and business value. The position involves leading the development and advancement of an integrated, multi-year lifecycle strategy that connects various functions including Commercial, Medical Affairs, and Market Access. The role requires establishing strategic context, creating shared ownership of the total lifecycle plan, and ensuring cross-functional perspectives are translated into clear priorities and coordinated execution.
Headquarters
San Diego, California, United States
Company Size
1001-5000 employees
Founded
1992
Neurocrine Biosciences is a biopharmaceutical company focused on discovering and developing treatments for patients with neurological, psychiatric, endocrine, and immunological disorders. With over 30 years of research, the company works to bring hope to people living with rare diseases and conditions that lack viable treatment options. Neurocrine develops and markets approved medicines while maintaining an active clinical pipeline across multiple therapeutic areas.
Neurocrine Biosciences to Present at the Stifel 2026 Virtual CNS Forum
1 day ago
Magnetar Financial LLC Acquires New Holdings in Neurocrine Biosciences, Inc. $NBIX
5 hours ago
Is It Time To Reassess Neurocrine Biosciences (NBIX) After The Recent Share Price Pullback
23 hours ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Neurocrine Biosciences.
53% above the average for this role
Capital Fund Management S.A. Has $17.37 Million Holdings in Neurocrine Biosciences, Inc. $NBIX
7 hours ago
Vice President, Medical Affairs, Hematology-Oncology
Nurix
Senior Director, Global Value, Access & Pricing NSCLC Oncology
Revolution Medicines
Senior Director, Medical Evidence Generation, Immunology
Celldex Therapeutics
Senior Global Medical Director, CKM
GSK plc
Medical Director Strategist
Azurity Pharmaceuticals
Senior Director, Medical Affairs
LeonaBio